Abstract：Objective: To explore the effect of Ai Sciplan on the neural function and cognitive function of patients with post-stroke depression. Methods: 82 stroke patients were selected in our hospital from October 2016 to October 2017 were patients with depression as the research object, it was divided into study group ( 41 cases ) and control group ( 41 cases ) by random number table method , two groups of patients were treated with routine drug treatment the study group, patients taking escitalopram on the basis of routine therapy, patients in control group received placebo on the basis of conventional drug treatment, continuous treatment for 12 weeks. The depression of two groups were compared before and after treatment, nerve function, the cognitive function and life ability The evaluation. Results: Before treatment, there was no significant difference in the HAMD score, NIHSS score, MMSE score and FIM score between the two groups (P>0.05). After treatment, the HAMD scores, NIHSS scores, MMSE scores and FIM scores of the two groups were all improved, and the observation group was significantly better than the control group (P<0.05). Conclusion: In the clinical treatment of post-stroke depression, the use of escitalopram can improve neurological function and cognitive function, as well as improve depression and viability of patients.
胡会婷, 王敏忠. 艾司西酞普兰治疗脑卒中后抑郁及对患者神经功能认知功能的影响[J]. 河北医学, 2018, 24(2): 325-328.
HU Huiting, WANG Minzhong. The Effect of Escitalopram on the Neurologic Function and Cognitive Function of the Post-stroke Depression Patients. HeBei Med, 2018, 24(2): 325-328.
[1] Wilz G, Barskova T. Predictors of psychological and somatic components of poststroke depression: a longitudinal study.[J]. Topics in Stroke Rehabilitation, 2014, 14(3):25~40. [2] Hamid G M, Mackenzie M A. CE: Early Intervention in patients with poststroke depression.[J]. American Journal of Nursing, 2017, 117(7):32. [3] 李菊芳,罗勇,李云,等.脑卒中后抑郁诊断及筛查工具研究进展[J].护理研究,2017,31(11):1298~1300. [4] 戴云飞,肖泽萍.中国精神障碍分类与诊断标准第3版与国际疾病分类第10版的比较[J].临床精神医学杂志,2013,23(6):426~427. [5] 赵振华,田云鹏,王广军.艾司西酞普兰对卒中后抑郁状态及神经康复的临床研究[J].临床精神医学杂志,2011,21(4):235. [6] Karaahmet O Z, Gurcay E, Avluk O C, et al. Poststroke depression: risk factors and potential effects on functional recovery[J]. International Journal of Rehabilitation Research, 2017, 40(1). [7] 贾璐,蒙华庆,徐中林,等.艾司西酞普兰治疗老年慢性心力衰竭伴抑郁症对患者认知功能和心功能的影响[J].重庆医学,2017,46(19):2652~2654. [8] 李继,王建军,李烨,等.草酸艾司西酞普兰对脑卒中后抑郁、认知及神经功能的影响[J].河北医科大学学报,2017,38(5):589~592. [9] 詹奕红,童绥君,安星凯,等.艾司西酞普兰对急性缺血性卒中患者运功功能恢复的影响[J].中国全科医学,2014,34(21):752~755.
2018, Vol. 24 
冀公网安备13080202000677号